Fiche publication
Date publication
août 2024
Journal
American journal of obstetrics and gynecology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr AKLADIOS Chérif
Tous les auteurs :
Jochum F, Dumas É, Gougis P, Hamy AS, Querleu D, Lecointre L, Gaillard T, Reyal F, Lecuru F, Laas E, Akladios C
Lien Pubmed
Résumé
The effect of primary cytoreductive surgery versus interval cytoreductive surgery on FIGO IV ovarian cancer outcomes remains uncertain, and may vary depending on the stage and the extraperitoneal metastasis location. Emulating target trials through causal assessment combined with propensity score adjustment has become a leading method for evaluating interventions using observational data.
Mots clés
FIGO stage IV, extraperitoneal metastases, interval cytoreductive surgery, ovarian cancer, overall survival, primary cytoreductive surgery, progression-free survival, target trial emulation
Référence
Am J Obstet Gynecol. 2024 08 5;:
